Charan Behl files SEC Form 4 disclosures for ELITE PHARMACEUTICALS INC /DE/. They have made 13 open-market trades across 1 company since 2008, most recently 2008-09-19.
CIK 0001350693
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
13 open-market purchases totalling $117K since 2008, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ELI | 600,000 | — |
Shares reported on the most recent Form 4, priced at the 2008-09-22 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ELI | BUY | 2008-09-19 | 2008-09-22 | $0.09 | $900 | N/A | N/A | N/A |
| ELI | BUY | 2008-07-23 | 2008-07-25 | $0.34 | $3K | N/A | N/A | N/A |
| ELI | BUY | 2008-07-21 | 2008-07-23 | $0.36 | $7K | N/A | N/A | N/A |
| ELI | BUY | 2008-07-17 | 2008-07-18 | $0.36 | $9K | N/A | N/A | N/A |
| ELI | BUY | 2008-07-15 | 2008-07-15 | $0.34 | $2K | N/A | N/A | N/A |
| ELI | BUY | 2008-07-09 | 2008-07-09 | $0.39 | $6K | N/A | N/A | N/A |
| ELI | BUY | 2008-04-02 | 2008-04-02 | $0.80 | $12K | N/A | N/A | N/A |
| ELI | BUY | 2008-03-28 | 2008-03-28 | $0.90 | $5K | N/A | N/A | N/A |
| ELI | BUY | 2008-03-26 | 2008-03-27 | $0.96 | $5K | N/A | N/A | N/A |
| ELI | BUY | 2008-02-07 | 2008-02-08 | $0.94 | $14K | N/A | N/A | N/A |
| ELI | BUY | 2008-02-05 | 2008-02-06 | $0.76 | $19K | N/A | N/A | N/A |
| ELI | BUY | 2008-01-29 | 2008-01-30 | $0.96 | $24K | N/A | N/A | N/A |
| ELI | BUY | 2008-01-25 | 2008-01-28 | $1.16 | $10K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.